CHINA FOODS (00506) releases its interim results, with a net profit attributable to shareholders of 578 million yuan, an increase of 2.23% year-on-year.
Chinese Food (00506) released its mid-term performance for 2025, with the group achieving revenue of RMB 12.278 billion...
China Foods (00506) announced its mid-term performance for 2025, with the group achieving revenue of 12.278 billion yuan (figures in the same unit), a year-on-year increase of 8.3%; adjusted EBITDA was 1.787 billion yuan, a year-on-year increase of 6.2%; and the net profit attributable to shareholders was 578 million yuan, a year-on-year increase of 2.23%; with an earnings per share of 20.66 cents.
The company is currently authorized to operate the Coca-Cola series products in a total of 19 provincial-level administrative regions, providing consumers with 10 major categories and 25 brands of products including soft drinks, juices, water, dairy beverages, energy drinks, tea, coffee, functional nutritional beverages, sports drinks, and plant-based protein beverages.
In the first half of this year, the sales volume of the company's Coca-Cola series products continued to grow, with outstanding market performance. Compared to the overall market trend in mainland China, the company not only maintained a steady increase in sales volume but also achieved a significant acceleration in revenue growth. This positive trend has further strengthened the company's market leadership position, demonstrating strong competitiveness and development momentum. In addition to Coca-Cola bottling business, the smart retail business has rapidly expanded its equipment scale and maintained its leading position in the industry. In another innovative platform, the COFCO YUEXIANG Club focuses on product price increases and the development of non-Coca-Cola product business, with a year-on-year increase in revenue. Looking ahead, our vision is to become a world-class food and beverage group.
Related Articles

Sinolink: Internal and external resonance + favorable policies, Chinese innovative drugs march towards the global stage.
Goldman Sachs Group, Inc.: The outlook for the second half of the year in the US retail industry is becoming more conservative, giving Target Corporation (TGT.US) a "neutral" rating.

Carlyle Group Inc (CG.US) has agreed to acquire Intelliflo, a software company owned by Invesco (IVZ.US), for up to $200 million.
Sinolink: Internal and external resonance + favorable policies, Chinese innovative drugs march towards the global stage.

Goldman Sachs Group, Inc.: The outlook for the second half of the year in the US retail industry is becoming more conservative, giving Target Corporation (TGT.US) a "neutral" rating.
Carlyle Group Inc (CG.US) has agreed to acquire Intelliflo, a software company owned by Invesco (IVZ.US), for up to $200 million.

RECOMMEND

Alibaba and Meituan Spend Billions, Yet the True Winners of the Food Delivery Battle Have Emerged
25/08/2025

Hong Kong Overtakes the U.S. as Mainland Companies’ Premier Offshore Listing Venue
25/08/2025

General Administration of Customs Reports Record Trade Oversight Since the 14th Five-Year Plan
25/08/2025